Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041472-07
Application #
6757899
Study Section
Special Emphasis Panel (ZRG1-SSS-4 (01))
Program Officer
Sawyer, Richard T
Project Start
1998-03-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
7
Fiscal Year
2004
Total Cost
$367,875
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Carroll, Daniela J; O'Sullivan, Jeremy A; Nix, David B et al. (2018) Sialic acid-binding immunoglobulin-like lectin 8 (Siglec-8) is an activating receptor mediating ?2-integrin-dependent function in human eosinophils. J Allergy Clin Immunol 141:2196-2207
Na, Ho Jeong; Hudson, Sherry A; Bochner, Bruce S (2012) IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils. Cytokine 57:169-74
Hudson, Sherry A; Herrmann, Harald; Du, Jian et al. (2011) Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression. J Clin Immunol 31:1045-53
Guo, Jin P; Brummet, Mary E; Myers, Allen C et al. (2011) Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs. Am J Respir Cell Mol Biol 44:238-43
Hudson, Sherry A; Bovin, Nicolai V; Schnaar, Ronald L et al. (2009) Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. J Pharmacol Exp Ther 330:608-12
Ogbogu, Princess U; Bochner, Bruce S; Butterfield, Joseph H et al. (2009) Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 124:1319-25.e3
Bochner, B S (2009) Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy 39:317-24
Zimmermann, N; McBride, M L; Yamada, Y et al. (2008) Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils. Allergy 63:1156-63